Home › Ductal Carcinoma In Situ (DCIS) › Michigan
Ductal Carcinoma In Situ (DCIS) clinical trials in Michigan
4 studies for Ductal Carcinoma In Situ (DCIS) are looking for participants at sites in Michigan.
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
- University of Michigan Rogel Cancer Center, Ann Arbor
RecruitingPhase 2Healthy volunteers welcome
Ages 45 to 74 · Women · Updated Aug 4, 2026 · NCT06195306Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
- University of Michigan Rogel Cancer Center, Ann Arbor
RecruitingPhase 2
Ages 18 to 55 · Women · Updated Jul 27, 2026 · NCT06184750The PREDICT Registry:
- Corewell Health William Beaumont University Center, Royal Oak
- Comprehensive Breast Care, Troy
RecruitingObservational study
Ages 30 to 85 · Women · Updated Apr 17, 2026 · NCT03448926A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
- Karmanos Cancer Institute, Detroit
Recruiting
Ages 18 and older · Women · Updated Sep 18, 2025 · NCT07095114From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.